News | Mammography | October 16, 2015

Findings demonstrate size of tumor, involvement of lymph nodes directly impact overall long-term survival

breast cancer, early detection, BMJ, Dutch study, Elaine Schattner, lymph nodes, tumor size

October 14, 2015 — Findings from a new population-based study in the Netherlands appear to reaffirm that early detection of breast cancer positively impacts long-term patient survival.

The study — based out of Erasmus University Medical Centre, the Netherlands Comprehensive Cancer Organization and the University of Twente and published in the BMJ — retrospectively looked at the cases of 174,000 Dutch women. The population was broken into two large cohorts: women diagnosed with breast cancer between 1999 and 2005 (80,228 women, median age 59) and women diagnosed 2006-2012 (93,569 women, median age 60). According to study authors, the two cohorts were selected due to significant changes in the screening guidelines in 2005.

Elaine Schattner, M.D., in a piece on the study for Forbes, said there are two key takeaways from the results:

  • Overall survival was significantly shorter for women whose breast cancer had spread to the lymph nodes; and
  • Larger, invasive tumors had a significantly greater impact on long-term survival than smaller invasive cancers.

Schattner also noted that data from the period of 2006-2012 indicated more early-stage diagnoses and low-grade tumors, increases in lumpectomy and increased use of medicines including hormonal treatments.

Study authors note that the Netherlands instituted a national biennial mammography screening program in 1989; the program was initially targeted for all women age 50-69 and was expanded to included women age 71-75 in 1998.

The Dutch study findings go against the modern view, held in some circles, that early detection has little value. According to Schattner, this view is largely based on a 2012 study in the New England Journal of Medicine that attributed improvements in breast cancer survival rates to better treatment options as opposed to mammography screening.

For more information: www.bmj.com


Related Content

News | Breast Imaging

Dec. 01, 2025 — DeepHealth, a wholly owned subsidiary of RadNet, Inc., has launched the DeepHealth Breast Suite,2 an end ...

Time December 04, 2025
arrow
News | Women's Health

Dec. 1, 2025 — ScreenPoint Medical has completed a commercial agreement making its Transpara breast-imaging AI portfolio ...

Time December 03, 2025
arrow
News | Mammography

Nov. 30, 2025 — At RSNA 2025, Siemens Healthineers will introduce new capabilities for its Mammomat B.brilliant ...

Time December 02, 2025
arrow
News | RSNA 2025

Dec. 2, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, will present 14 studies at RSNA ...

Time December 02, 2025
arrow
News | Women's Health

Dec. 1, 2025 — A study of data from seven outpatient facilities in the New York region found that 20-24% of all the ...

Time December 02, 2025
arrow
News | Mammography

Nov. 26, 2025 — GE HealthCare has announced it received FDA Premarket Authorization for Pristina Recon DL, an advanced ...

Time November 29, 2025
arrow
News | Artificial Intelligence

Nov. 25, 2025 – Medical imaging AI company Avicenna.AI has announced a strategic partnership with Ferrum, an AI ...

Time November 25, 2025
arrow
News | Ultrasound Imaging

Nov. 12, 2025 — GE HealthCare and DeepHealth, Inc., a wholly owned subsidiary of RadNet, Inc., have announced their ...

Time November 20, 2025
arrow
News | Breast Imaging

Nov. 17, 2025 — RadNet, Inc. and its wholly owned subsidiary, DeepHealth have announced results from the largest real ...

Time November 17, 2025
arrow
News | Radiology Business

Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...

Time November 13, 2025
arrow
Subscribe Now